Vimarsana
Biggest News Aggregation in the World

Brooke Raphael News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Brooke Raphael. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Brooke Raphael Today - Breaking & Trending Today

Promontory Therapeutics Presents Data on Molecular Mechanisms of PT-112's Immunogenic Effects - Vimarsana News

Promontory Therapeutics Presents Data on Molecular Mechanisms of PT-112's Immunogenic Effects

Published: November 4, 2023

/PRNewswire/ -- Promontory Therapeutics Inc., a Phase 2 stage biotech company advancing immunogenic small molecule approaches in oncology, today presented data...

Source: prnewswire.com
Related Topics:
United StatesSan DiegoNew YorkFrance GeneralBrooke RaphaelStan MusialAlexis FeinbergNational Cancer InstitutePromontory Therapeutics IncDevelopment Tyler AmesGalluzzi Lab At Weill Cornell Medical CollegeSociety For Immunotherapy Of CancerAnnual MeetingGalluzzi LabWeill Cornell Medical CollegePromontory Therapeutics Senior Vice PresidentPromontory TherapeuticsParis Saclay Cancer ClusterPromontory Therapeutics IncHealth Care Amp HospitalsMedical Pharmaceuticals Trade Show NewsClinical Trials Amp Medical Discoveries
Promontory Therapeutics Presents Data on the Molecular Effects of PT-112 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics - Vimarsana News

Promontory Therapeutics Presents Data on the Molecular Effects of PT-112 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Published: October 14, 2023

/PRNewswire/ -- Promontory Therapeutics Inc., a clinical stage biotech company advancing immunogenic small molecule approaches in oncology, today presented...

Source: prnewswire.com
Related Topics:
United StatesFrance GeneralStan MusialBrooke RaphaelTyler AmesAlexis FeinbergEuropean Organisation For ResearchBaylor College Of MedicinePromontory Therapeutics IncPrnewswire Promontory Therapeutics IncAmerican Association For Cancer ResearchInternational Conference On MolecularVirtual CongressNational Cancer InstituteTherapeutics IncAmerican AssociationCancer ResearchEuropean OrganisationInternational ConferenceMolecular TargetsCancer TherapeuticsPromontory Therapeutics Senior Vice PresidentBaylor CollegeArpeggio BiosciencesPromontory Therapeutics
Promontory Therapeutics Announces Early Phase 2 Clinical Trial Data From the National Cancer Institute, Demonstrating PT-112's Immune Activation in Thymic Epithelial Tumors - Vimarsana News

Promontory Therapeutics Announces Early Phase 2 Clinical Trial Data From the National Cancer Institute, Demonstrating PT-112's Immune Activation in Thymic Epithelial Tumors

Published: October 5, 2023

/PRNewswire/ -- The National Cancer Institute (NCI), part of the National Institutes of Health, under formal collaboration with Promontory Therapeutics Inc., a...

Source: prnewswire.com
Related Topics:
New YorkUnited StatesFrance GeneralMemorial Sloan Kettering Cancer CenterBrooke RaphaelStan MusialJohan BaeckVarun RajanAlexis FeinbergInternational Thymic Malignancy Interest GroupVirtual CongressSloan Kettering Cancer CenterNational Cancer InstituteNational Institutes Of HealthPromontory Therapeutics IncSloan Kettering CancerNational InstitutesPrincipal InvestigatorParis Saclay Cancer ClusterPromontory TherapeuticsPromontory Therapeutics Inc
Promontory Therapeutics Announces Preliminary Data from the National Cancer Institute Phase 2 Clinical Trial of PT-112 in Thymoma and Thymic Carcinoma at 2023 ASCO Annual Meeting - Vimarsana News

Promontory Therapeutics Announces Preliminary Data from the National Cancer Institute Phase 2 Clinical Trial of PT-112 in Thymoma and Thymic Carcinoma at 2023 ASCO Annual Meeting

Published: June 2, 2023

/PRNewswire/ -- Promontory Therapeutics Inc., a clinical stage pharmaceutical company advancing small molecule immunotherapies in oncology, announces...

Source: prnewswire.com
Related Topics:
United StatesBrooke RaphaelStan MusialJohan BaeckAlexis FeinbergNational Institutes Of HealthMerck KgaaVirtual CongressNational Cancer InstituteAmerican Society Of Clinical OncologyPrnewswire Promontory Therapeutics IncPromontory Therapeutics IncMerck KgaTherapeutics IncNational InstitutesClinical OncologyOrphan DrugPromontory TherapeuticsPromontory Therapeutics IncHealth Care Amp HospitalsMedical Pharmaceuticals Pharmaceuticals Clinical Trials Amp Medical DiscoveriesTrade Show News
Promontory Therapeutics to Participate in Business Development Strategies Panel at the Sachs 9th Annual Immuno-Oncology Innovation Forum - Vimarsana News

Promontory Therapeutics to Participate in Business Development Strategies Panel at the Sachs 9th Annual Immuno-Oncology Innovation Forum

Published: May 31, 2023

/PRNewswire/ -- Promontory Therapeutics Inc., a clinical stage pharmaceutical company advancing small molecule immunotherapies in oncology, will participate in...

Source: prnewswire.com
Related Topics:
United StatesMatthew PriceStan MusialAlexis FeinbergJohan BaeckBrooke RaphaelBusiness Development Strategies PanelPrnewswire Promontory Therapeutics IncPanel Discussion DetailsPanel SessionMerck KgaSachs ForumPromontory Therapeutics IncMerck KgaaWaldorf Astoria HotelOncology Innovation ForumTherapeutics IncAnnual Immuno Oncology Innovation ForumMaximize ValueCapital EfficientSinclair BallroomRoom FaulknerOrphan DrugPromontory TherapeuticsPromontory Therapeutics Inc